Close Menu

Daniel Gibson says that being able to synthesize new genomes may "dramatically speed up the process of engineering microbes that can carry out tasks such as efficiently producing biofuels or vaccines," as he tells MIT's Technology Review. Last year, Gibson's team at the J. Craig Venter Institute announced that they made a synthetic genome using yeast cells to assemble the oligonucleotides, and Gibson has now developed a way of doing that without the yeast.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.